Clinical Trial Update: TUS to Disrupt Pathological Oscillations [NA]

View source ↗

Summary

University of Oxford is testing transcranial ultrasound (TUS) to disrupt pathological brain oscillations in Parkinson disease. The trial is currently enrolling …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Oxford | Conditions: Parkinson Disease | NA | Status: ENROLLING_BY_INVITATION